Puma Biotechnology, Inc. (PBYI)
Puma Biotechnology Market Cap: 281.94M for Dec. 10, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Nephros, Inc. | 54.83M |
| Sensus Healthcare, Inc. | 65.78M |
| ACADIA Pharmaceuticals, Inc. | 4.535B |
| Vanda Pharmaceuticals, Inc. | 397.72M |
| Vertex Pharmaceuticals, Inc. | 112.79B |
Market Cap Related Metrics
| PE Ratio | 7.554 |
| PS Ratio | 1.322 |
| PEG Ratio | 0.1350 |
| Price to Book Value | 2.446 |
| Price to Free Cash Flow | 6.539 |
| Price | 5.595 |
| Earnings Yield | 13.24% |
| PEGY Ratio | 0.1350 |
| Operating PE Ratio | 8.353 |
| Normalized PE Ratio | 7.554 |